The clinical use of monthly injectable contraceptive preparations
Toppozada, M.
Obstetrical and Gynecological Survey 32(6): 335-347
1977
ISSN/ISBN: 0029-7828 PMID: 865726 DOI: 10.1097/00006254-197706000-00001Document Number: 439511
Document emailed within 0-6 h
Related Documents
Baweja, R.; Bhattacharya, S.K.; Choudhury, S.D.; Krishna, U.; Manuel, M.; Phillips, F.S.; Datey, S.; Kumar, S.; Mehta, S.; Saxena, N.C. 1985: Indian Council of Medical Research. Task Force on Hormonal Contraception: Phase II randomized clinical trial with norethisterone oenanthate 50 mg alone and in combination with 5 mg or 2.5 mg of either estradiol valerate or cypionate as a monthly injectable contraceptive Contraception 32(4): 383-394Cuong, D.T.; My Huong, N.T. 1996: Comparative phase III clinical trial of two injectable contraceptive preparations, depot-medroxyprogesterone acetate and cyclofem, in Vietnamese women Contraception 54(3): 169-179
Thurman, A.; Kimble, T.; Hall, P.; Schwartz, J.L.; Archer, D.F. 2013: Medroxyprogesterone acetate and estradiol cypionate injectable suspension (Cyclofem) monthly contraceptive injection: steady-state pharmacokinetics Contraception 87(6): 738-743
Zathurecky, L.; Bauerova, O.; Somoskeoey, G.; Molnar, L.; Suchy, S. 1963: Stability of Cardenolides of the Strophanthidin type in Injectable Preparations. Iii. Preparations of Stable Injectable Solutions of Helveticoside Ceskoslovenska Farmacie 12: 171-177
Kamischke, A.; Heuermann, T.; Krüger, K.; von Eckardstein, S.; Schellschmidt, I.; Rübig, A.; Nieschlag, E. 2002: An effective hormonal male contraceptive using testosterone undecanoate with oral or injectable norethisterone preparations Journal of Clinical Endocrinology and Metabolism 87(2): 530-539
Recio, R.; Garza-flores, J. 1988: Monthly injectable contraceptives Advances in Contraceptive Delivery Systems: Cds 4(4): 329-347
Recio, R.; Garza-flores, J. 1988: Monthly injectable contraceptives Advances in Contraceptive Delivery Systems: Cds 4(4): 329-347
Kamischke, A.; Heuermann, T.; Krueger, K.; Von Eckardstein, S.; Nieschlag, E. 2001: Injectable testosterone undecanoate with oral or injectable norethisterone preparations for male contraception Journal of Andrology (Suppl): 193
Skegg, D.C. 1994: Monthly combined injectable contraceptives and neoplasia Contraception 49(5): 435-439
Beksinska, M.E.; Rees, V.H.; Nkonyane, T.; McIntyre, J.A. 1998: Compliance and use behaviour, an issue in injectable as well as oral contraceptive use? a study of injectable and oral contraceptive use in Johannesburg British Journal of Family Planning 24(1): 21-23
Beksinska, M.E.; Rees, V.H.; Nkonyane, T.; McIntyre, J.A. 1998: Compliance and use behaviour, an issue in injectable as well as oral contraceptive use? a study of injectable and oral contraceptive use in Johannesburg British Journal of Family Planning 24(1): 21-23
Chowdhury, T.A. 1985: A clinical study on injectable contraceptive Noristerat Bangladesh Medical Journal 14(2-3): 28-35
Chowdhury, T.A. 1985: A clinical study on injectable contraceptive Noristerat Bangladesh Medical Journal 14(2-3): 28-35
Shulman, L.P. 2000: Expanding contraceptive choices: lunelle monthly contraceptive injection International Journal of Fertility and Women's Medicine 45(2): 190-194
Shulman, L.P. 2000: Expanding contraceptive choices: lunelle monthly contraceptive injection International Journal of Fertility and Women's Medicine 45(2): 190-194
Chaudhuri, C.; Mukherjea, M. 1984: Clinical trial of a long-acting injectable contraceptive: NET-EN Contraceptive Delivery Systems 5(1): 47-52
Guha, S.K.; Singh, G.; Anand, S.; Ansari, S.; Kumar, S.; Koul, V. 1993: Phase I clinical trial of an injectable contraceptive for the male Contraception 48(4): 367-375
Guha, S.K.; Singh, G.; Ansari, S.; Kumar, S.; Srivastava, A.; Koul, V.; Das, H.C.; Malhotra, R.L.; Das, S.K. 1997: Phase II clinical trial of a vas deferens injectable contraceptive for the male Contraception 56(4): 245-250
Singh, M.; Saxena, B.B.; Graver, R.; Ledger, W.J. 1989: Contraceptive efficacy of norethindrone encapsulated in injectable biodegradable poly-dl-lactide-co-glycolide microspheres: phase Ii clinical study Fertility and Sterility 52(6): 973-980
Kesserü, E.; Albornoz, H.; Díaz, M.; Socolsky, R. 1991: Serum lipid variations in women on copper intrauterine devices, triphasic oral contraceptives and monthly injectable contraceptives Contraception 44(3): 235-244